B · Normal
[Chinese original technology provides new solutions for the global treatment of hypertrophic cardiomyopathy] On November 17th, "Circulation", the top international cardiovascular journal, published two articles on November 17th, Beijing time, introducing the latest results of Professor Wei Xiang's team from the Cardiac Surgery Department of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology in the treatment of hypertrophic cardiomyopathy, and systematically presented the team's first transapical beating ventricular septal myectomy (TA-BSM). This minimally invasive procedure effectively covers the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, breaks through the limitations of traditional treatment, and provides a Chinese solution for the global treatment of hypertrophic cardiomyopathy.
Comments